NCT00002232View on ClinicalTrials.gov

A Study of GENEVAX-HIV, a Possible Vaccine

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV InfectionsHIV Seronegativity

Interventions

BIOLOGICAL

APL 400-003

Trial Locations (1)

20307

Walter Reed Army Institute of Research, Washington D.C.

All Listed Sponsors

lead

Wyeth-Lederle Vaccines

INDUSTRY

NCT00002232 - A Study of GENEVAX-HIV, a Possible Vaccine | Biotech Hunter | Biotech Hunter